GHSI guardionhealth.com: Nilai bisnis marang pendapatan

Guardion Health Science (GHSI) is expanding its ophthalmological pharmaceutical presence through partnerships with clinics and nutritionists. The EV/Sales multiple trend visualizes the distribution synergy of Lumega-Z, with the metric currently standing at . Management is currently finalizing asset liquidation for shareholder payouts. Business revenues are based on pharmacy sales and a scientific foundation of drug efficacy, which directly impacts the stability of component supplies.
GHSI (Guardion Health Science): rincian analitis lan laporan miturut indikator

Scalability constraints for Guardion Health Science (GHSI), driven by ophthalmology market saturation and high marketing expenditures, are hindering growth in operational efficiency. The EV/Sales multiple quantifies the total enterprise value relative to revenue excluding debt, enabling investors to distinguish the asset's fundamental strength from a speculative rally and recognize overvaluation risks in a timely manner by monitoring the chart.